Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies

Episode von Medizin - Open Access LMU - Teil 17/22 von Ludwig-Maximilians-Universität München · 1. Januar 2010

Background: Epithelial cell adhesion molecule (EpCAM) is frequently and highly expressed on human carcinomas. The emerging role of EpCAM as a signalling receptor and activator of the wnt pathway, and its expression on tumor-initiating cells, further add to its attractiveness as target for immunotherapy of cancer. Thus far, five conventional monoclonal IgG antibodies have been tested in cancer patients. These are murine IgG2a edrecolomab and its murine/human chimeric IgG1 antibody version, and humanized, human-engineered and fully human IgG1 antibodies 3622W94, ING-1, and adecatumumab (MT201), respectively. Here we compared all anti-EpCAM antibodies in an attempt to explain differences in clinical activity and safety. Methods: We recombinantly produced all antibodies but murine edrecolomab and investigated them for binding affinity, EpCAM epitope recognition, ADCC and CDC, and inhibition of breast cancer cell proliferation. Results: ING-1 and 3622W94 bound to EpCAM with much higher affinity than adecatumumab and edrecolomab. Edrecolomab, ING-1, and 3622W94 all recognized epitopes in the exon 2-encoded N-terminal domain of EpCAM, while adecatumumab recognized a more membrane proximal epitope encoded by exon 5. All antibodies induced lysis of EpCAM-expressing cancer cell lines by both ADCC and CDC with potencies that correlated with their binding affinities. The chimeric version of edrecolomab with a human Fc gamma 1 domain was much more potent in ADCC than the murine IgG2a version. Only adecatumumab showed a significant inhibition of MCF-7 breast cancer cell proliferation in the absence of complement and immune cells. Conclusion: A moderate binding affinity and recognition of a distinct domain of EpCAM may best explain why adecatumumab showed a larger therapeutic window in cancer patients than the two high-affinity IgG1 antibodies ING-1 and 3622W94, both of which caused acute pancreatitis.

Weitere Episoden von „Medizin - Open Access LMU - Teil 17/22“

• 200 years Organon of Medicine - A comparative Review of its six editions (1810-1842) 1. Januar 2010
• A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons 1. Januar 2010
• Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season 1. Januar 2010
• Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC) 1. Januar 2010
• Amiloride reduces portal hypertension in rat liver cirrhosis 1. Januar 2010
• Association between exposure to radiofrequency electromagnetic fields assessed by dosimetry and acute symptoms in children and adolescents: a population based cross-sectional study 1. Januar 2010
• Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis 1. Januar 2010
• Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome 1. Januar 2010
• Deqi sensations without cutaneous sensory input: results of an RCT 1. Januar 2010
• Diagnostic indices for vertiginous diseases 1. Januar 2010
• How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials 1. Januar 2010
• Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement 1. Januar 2010
• Increased expression of 5-hydroxytryptamine(2A/B) receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention 1. Januar 2010
• LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer 1. Januar 2010
• Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP) 1. Januar 2010

Alle Episoden von Medizin - Open Access LMU - Teil 17/22 · Mehr Bildung-Podcasts